Pharma Native ApS — Credit Rating and Financial Key Figures
CVR number: 44114976
Betonvej 10, 4000 Roskilde
je@pharma-native.com
tel: 30995258
www-pharma-native.com
Income statement (kDKK)
2023 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| Gross profit | 848.52 |
| Employee benefit expenses | - 489.37 |
| EBIT | 359.15 |
| Other financial income | 0.03 |
| Other financial expenses | -9.47 |
| Pre-tax profit | 349.72 |
| Income taxes | -78.25 |
| Net earnings | 271.46 |
Assets (kDKK)
2023 | |
|---|---|
| Intangible assets total | |
| Tangible assets total | |
| Investments total | 17.25 |
| Long term receivables total | |
| Inventories total | |
| Current trade debtors | 460.27 |
| Prepayments and accrued income | 8.40 |
| Short term receivables total | 468.67 |
| Cash and bank deposits | 146.00 |
| Cash and cash equivalents | 146.00 |
| Balance sheet total (assets) | 631.92 |
Equity and liabilities (kDKK)
2023 | |
|---|---|
| Share capital | 40.00 |
| Shares repurchased | 122.00 |
| Retained earnings | - 122.00 |
| Profit of the financial year | 271.46 |
| Shareholders equity total | 311.46 |
| Non-current liabilities total | |
| Current owed to participating | 3.32 |
| Short-term deferred tax liabilities | 84.28 |
| Other non-interest bearing current liabilities | 232.86 |
| Current liabilities total | 320.46 |
| Balance sheet total (liabilities) | 631.92 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.